fluticasone propionate and salmeterol
These highlights do not include all the information needed to use FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER safely and effectively. See full prescribing information for FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER. FLUTICASONE PROPIONATE and SALMETEROL inhalation powder, for oral inhalation use Initial U.S. Approval: 2000
ce347bf4-4cc1-46dc-b5f1-6f8ff48da84b
HUMAN PRESCRIPTION DRUG LABEL
Sep 28, 2022
Teva Pharmaceuticals USA, Inc.
DUNS: 001627975
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
fluticasone propionate and salmeterol
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (2)
fluticasone propionate and salmeterol
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (2)
fluticasone propionate and salmeterol
Product Details
FDA regulatory identification and product classification information